标题
QcrB in
Mycobacterium tuberculosis
: The new drug target of antitubercular agents
作者
关键词
-
出版物
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-01-06
DOI
10.1002/med.21779
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds
- (2020) Garrett C. Moraski et al. PLoS One
- New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis
- (2020) Andréanne Lupien et al. PLoS Pathogens
- Respiratory supercomplexes III2IV2 come into focus
- (2019) Joana S. Sousa et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- An overview of new antitubercular drugs, drug candidates, and their targets
- (2019) Aparna Bahuguna et al. MEDICINAL RESEARCH REVIEWS
- Identification of 4-Amino-Thieno[2,3-d]Pyrimidines as QcrB Inhibitors in Mycobacterium tuberculosis
- (2019) Gregory A. Harrison et al. mSphere
- Cytochrome bd in Mycobacterium tuberculosis: A respiratory chain protein involved in the defense against antibacterials
- (2019) Ludovica Mascolo et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels
- (2018) Theresa O'Malley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing
- (2018) Fernanda Teixeira Subtil et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB
- (2018) Laura A. T. Cleghorn et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure of a functional obligate complex III2IV2 respiratory supercomplex from Mycobacterium smegmatis
- (2018) Benjamin Wiseman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- An electron transfer path connects subunits of a mycobacterial respiratory supercomplex
- (2018) Hongri Gong et al. SCIENCE
- Pyrazolo[1,5-a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis
- (2018) Xiaoyun Lu et al. ACS Infectious Diseases
- Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203
- (2017) Sunhee Kang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pyrazolo[1,5-a]pyridine-3-carboxamide hybrids: Design, synthesis and evaluation of anti-tubercular activity
- (2017) Xiaoyun Lu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis
- (2017) Subramanyam J. Tantry et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mycobacterial Membrane Proteins QcrB and AtpE: Roles in Energetics, Antibiotic Targets, and Associated Mechanisms of Resistance
- (2017) Luke Bown et al. JOURNAL OF MEMBRANE BIOLOGY
- Exploiting the synthetic lethality between terminal respiratory oxidases to killMycobacterium tuberculosisand clear host infection
- (2017) Nitin P. Kalia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Energy Metabolism in Mycobacterium tuberculosis , a New Paradigm in Antimycobacterial Drug Discovery
- (2017) Dirk Bald et al. mBio
- Decoding the similarities and differences among mycobacterial species
- (2017) Sony Malhotra et al. PLoS Neglected Tropical Diseases
- Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrB
- (2017) N. Susantha Chandrasekera et al. ACS Infectious Diseases
- Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides
- (2016) Eleni Pitta et al. JOURNAL OF MEDICINAL CHEMISTRY
- The architecture of the mammalian respirasome
- (2016) Jinke Gu et al. NATURE
- Structure of a bd oxidase indicates similar mechanisms for membrane-integrated oxygen reductases
- (2016) Schara Safarian et al. SCIENCE
- SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc1 inhibitors
- (2016) Narisa Phummarin et al. MedChemComm
- 2-(Quinolin-4-yloxy)acetamides Are Active against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains
- (2016) Kenia Pissinate et al. ACS Medicinal Chemistry Letters
- Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB
- (2016) Garrett C. Moraski et al. ACS Infectious Diseases
- Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening
- (2015) Ujjini H. Manjunatha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Isolation and Characterization of a Hybrid Respiratory Supercomplex Consisting ofMycobacterium tuberculosisCytochromebccandMycobacterium smegmatisCytochromeaa3
- (2015) Mi-Sun Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity
- (2015) N. Susantha Chandrasekera et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial Respiration
- (2015) Renier van der Westhuyzen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents
- (2015) Jian Tang et al. ACS Medicinal Chemistry Letters
- Lansoprazole is an antituberculous prodrug targeting cytochrome bc1
- (2015) Jan Rybniker et al. Nature Communications
- Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and “Anagrams” Generated Potent Antituberculosis Agents
- (2015) Garrett C. Moraski et al. ACS Infectious Diseases
- Energy Metabolism and Drug Efflux in Mycobacterium tuberculosis
- (2014) P. A. Black et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Respiratory Flexibility in Response to Inhibition of CytochromecOxidase in Mycobacterium tuberculosis
- (2014) Kriti Arora et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ATP synthase in mycobacteria: Special features and implications for a function as drug target
- (2014) Ping Lu et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion
- (2014) Jan Rybniker et al. Cell Host & Microbe
- Tuberculosis drug discovery in the post-post-genomic era
- (2014) Benoit Lechartier et al. EMBO Molecular Medicine
- Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent
- (2014) Sunhee Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bactericidal Activity of an Imidazo[1, 2-a]pyridine Using a Mouse M. tuberculosis Infection Model
- (2014) Yong Cheng et al. PLoS One
- Bedaquiline for the treatment of resistant tuberculosis: Promises and pitfalls
- (2014) Ashish Kumar Kakkar et al. TUBERCULOSIS
- Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series
- (2013) Sreekanth Ramachandran et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A medicinal chemists’ guide to the unique difficulties of lead optimization for tuberculosis
- (2013) Véronique Dartois et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
- (2013) Lluís Ballell et al. ChemMedChem
- Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents
- (2013) Venkatesham Rachakonda et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
- (2013) Katherine A. Abrahams et al. PLoS One
- Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
- (2013) Robert C. Goldman TUBERCULOSIS
- Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and nM Activity vs. Mycobacterium tuberculosis
- (2013) Garrett C. Moraski et al. ACS Medicinal Chemistry Letters
- A High-Throughput Screen To Identify Inhibitors of ATP Homeostasis in Non-replicating Mycobacterium tuberculosis
- (2012) Puiying A. Mak et al. ACS Chemical Biology
- Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds
- (2012) Garrett C. Moraski et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Antituberculosis Drug Research: A Critical Overview
- (2012) Beena et al. MEDICINAL RESEARCH REVIEWS
- Identification and Validation of Tetracyclic Benzothiazepines as Plasmodium falciparum Cytochrome bc1 Inhibitors
- (2011) Carolyn K. Dong et al. CHEMISTRY & BIOLOGY
- High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv
- (2011) Robert C. Reynolds et al. TUBERCULOSIS
- Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity
- (2011) Garrett C. Moraski et al. ACS Medicinal Chemistry Letters
- Respiratory ATP synthesis: the new generation of mycobacterial drug targets?
- (2010) Dirk Bald et al. FEMS MICROBIOLOGY LETTERS
- Unique Flexibility in Energy Metabolism Allows Mycobacteria to Combat Starvation and Hypoxia
- (2010) Michael Berney et al. PLoS One
- Functionalized 3-amino-imidazo[1,2-a]pyridines: A novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors
- (2009) Luke R. Odell et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
- (2009) Subramaniam Ananthan et al. TUBERCULOSIS
- The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis
- (2008) S. P. S. Rao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential efficacy of inhibition of mitochondrial and bacterial cytochrome bc1 complexes by center N inhibitors antimycin, ilicicolin H and funiculosin
- (2007) Frederik A.J. Rotsaert et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started